Although the molecular mechanisms of MLP-associated cardiomyopathy are not known, they likely, at least in part, involve alterations in protein interactions and the oligomerization state, and perhaps a change in subcellular localization. This evidence concerns the gene CSRP3 and cardiomyopathy.